Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Augmedix Inc before investing.

In this article, we go over a few key elements for understanding Augmedix Inc’s stock price such as:

• Augmedix Inc’s current stock price and volume
• Why Augmedix Inc’s stock price changed recently
• Upgrades and downgrades for AUGX from analysts
• AUGX’s stock price momentum as measured by its relative strength

About Augmedix Inc (AUGX)

Before we jump into Augmedix Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.

Want to learn more about Augmedix Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Augmedix Inc.

What Caused Augmedix Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 30, 2023, there were 0 analysts who downgraded Augmedix Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Augmedix Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Augmedix Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Augmedix Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Augmedix Inc (AUGX) by visiting AAII Stock Evaluator.

Relative Price Strength of Augmedix Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 30, 2023, Augmedix Inc has a weighted four-quarter relative price strength of 38.17%, which translates to a Momentum Score of 98 and is considered to be Very Strong.

Want to learn more about how Augmedix Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Augmedix Inc Stock Price: Bottom Line

As of December 1, 2023, Augmedix Inc’s stock price is $5.63, which is up 6.63% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Augmedix Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.